ArticleBioengineered2026
Statement of Retraction: WD repeat domain 62 (WDR62) promotes resistance of colorectal cancer to oxaliplatin through modulating mitogen-activated protein kinase (MAPK) signaling.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.